Aug 13 (Reuters) – Zealand Pharma A/S: * SAID ON WEDNESDAY ENTERED INTO A USD 100 MILLION ROYALTY PURCHASE AND SALE AGREEMENT WITH ROYALTY PHARMA FOR THE ECONOMICS RELATED TO RUSFERTIDE Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)